Quest Diagnostics (DGX) Tops Q4 EPS by 6c; Guides FY11
Quest Diagnostics Inc. (NYSE: DGX) reported Q4 EPS of $0.97 ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
